EX-21.1 6 ex21-1.htm

 

Exhibit 21.1

 

LIST OF SUBSIDIARIES

 

Subsidiary   Ownership   Country
NeuroAirmid Therapeutics, Inc.   50%   USA
ReCyte Therapeutics, Inc.   94.8%   USA
Reverse Bioengineering, Inc.   100%   USA
UniverXome Bioengineering, Inc.   100%   USA
Canaria Transaction Corporation   100%   USA